Dellapasqua, S., Aliaga, P. T., Munzone, E., Bagnardi, V., Pagan, E., Montagna, E., . . . Colleoni, M. (2021). Pegylated Liposomal Doxorubicin (Caelyx<sup>®</sup>) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial. MDPI AG.
Chicago Style (17th ed.) CitationDellapasqua, Silvia, et al. Pegylated Liposomal Doxorubicin (Caelyx<sup>®</sup>) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial. MDPI AG, 2021.
MLA (9th ed.) CitationDellapasqua, Silvia, et al. Pegylated Liposomal Doxorubicin (Caelyx<sup>®</sup>) as Adjuvant Treatment in Early-Stage Luminal B-like Breast Cancer: A Feasibility Phase II Trial. MDPI AG, 2021.
Warning: These citations may not always be 100% accurate.